Raines Heather has filed 3 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 4197890 shares of PROVECTUS BIOPHARMACEUTICALS, INC. ($PVCT) on December 02, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2024 | PROVECTUS BIOPHARMACEUTICALS, INC. | $PVCT | Raines Heather | CFO | A | Stock Options (Right to Buy) | 4197890 | $0.00 | 4,197,890.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | PROVECTUS BIOPHARMACEUTICALS, INC. | $PVCT | Raines Heather | CFO | D | 8% Unsecured Convertible Promissory Note due 2022 | 50000 | $50000.00 | 125,000.0000 | 0 | 28.57% | 0.00% |
| Feb. 2, 2024 | PROVECTUS BIOPHARMACEUTICALS, INC. | $PVCT | Raines Heather | CFO | D | 8% Unsecured Convertible Promissory Note due 2022 | 25000 | $25000.00 | 175,000.0000 | 0 | 12.50% | 0.00% |